Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Target knockdown after systemic OTV administration in mice

ABSTRACT: Target knockdown after systemic OTV administration in mice

PROVIDER: PRJNA832805 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18958949.fastq.gz	Fastqsanger.gz
	SRR18958950.fastq.gz	Fastqsanger.gz
	SRR18958951.fastq.gz	Fastqsanger.gz
	SRR18958952.fastq.gz	Fastqsanger.gz
	SRR18958953.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 22

Similar Datasets

Target knockdown after systemic OTV administration in mice

Project description:Using single nucleus RNA sequencing, we knockdown of Malat1 across all cell types upon peripheral administration of OTV:Malat1.

2024-02-12 | GSE201741 | GEO

Head to head comparison of target knockdown following OTV vs. anti-TfR:ASO administration in mice

Project description:Using single nucleus RNA sequencing, we determined that peripheral administration of OTV:Malat1 results in much more widespread and robust target knockdown throughout the mouse brain compared to anti-TfR:Malat1.

2024-02-12 | GSE201787 | GEO

Head to head comparison of target knockdown following OTV vs. anti-TfR:ASO administration in mice

Project description:Head to head comparison of target knockdown following OTV vs. anti-TfR:ASO administration in mice

| PRJNA833038 | ENA

sucralose administration in mice

Project description:sucralose administration in mice Raw sequence reads

| PRJNA787401 | ENA

Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer’s disease mouse model.

Project description:Background: In Alzheimer’s disease (AD), microglia surround extracellular plaques and mount a sustained inflammatory response, contributing to the pathogenesis of the disease. Identifying approaches to specifically target plaque-associated microglia (PAMs) without interfering in the homeostatic functions of non-plaque associated microglia would afford a powerful tool and potential therapeutic avenue. Methods: Here, we demonstrated that a systemically administered nanomedicine, hydroxyl dendrimers (HDs), can cross the blood brain barrier and are preferentially taken up by PAMs in a mouse model of AD. As proof of principle, to demonstrate biological effects in PAM function, we treated the 5xFAD mouse model of amyloidosis for 4 weeks via systemic administration (ip, 2x weekly) of HDs conjugated to a colony stimulating factor-1 receptor (CSF1R) inhibitor (D-45113). Results: Treatment resulted in significant reductions in amyloid-beta (Aβ) and a stark reduction in the number of microglia and microglia-plaque association in the subiculum and somatosensory cortex, as well as a downregulation in microglial, inflammatory, and synaptic gene expression compared to vehicle treated 5xFAD mice. Conclusions: This study demonstrates that systemic administration of a dendranib may be utilized to target and modulate PAMs.

2024-05-07 | GSE266470 | GEO

Systemic Transcriptional Phenotypes in Mecp2 Null Mice

Project description:Systemic Transcriptional Phenotypes in Mecp2 Null Mice

| PRJNA588091 | ENA

Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges

Project description:Bacterial flagellin is a dominant innate immune activator of the intestine. Therefore, we examined the role of the intracellular flagellin receptor, NLRC4, in protecting the gut and/or driving inflammation. In accord with NLRC4 acting via transcription-independent pathways, loss of NLRC4 did not reduce the rapid robust changes in intestinal gene expression induced by flagellin administration. Loss of NLRC4 did not alter basal intestinal homeostasis nor predispose mice to development of colitis upon administration of an anti-IL-10R monoclonal antibody. However, in response to epithelial injury induced by dextran sulfate sodium (DSS), loss of NLRC4 resulted in more severe disease indicating a role for NLRC4 in protecting the gut. Moreover, loss of NLRC4 resulted in increased mortality in response to flagellate, but not aflagellate Salmonella infection. Thus, despite not being involved in rapid intestinal gene remodeling upon detection of flagellin, NLRC4-mediated inflammasome activation protects mice from mucosal and systemic challenges Flagellin (FliC) from WT Salmonella enterica serovar Typhimurium (SL3201, fljB–) was purified through sequential cation and anion-exchange chromatography and purity was verified as previously described 4. WT, T5KO, N4KO and T5/N4-DKO mice (n=6) were given either 0.2 mL PBS or flagellin (10μg/mouse in 0.2 mL PBS) intraperitoneally. After 1h, mice were euthanized and colon was taken and stored in RNAlater (Invitrogen) for 1 day. Total mRNA was isolated from colonic tissues using TRIzol (Invitrogen) and purified using the RNeasy® Plus Mini kit (Qiagen) according to the manufacturer’s instructions

2012-01-01 | E-GEOD-34492 | biostudies-arrayexpress

Differential gene expression in mice liver following apigenin administration

Project description:Differential gene expression in mice liver after apigenin administration. Gene expression from control mice were compared with apigenin treated mice at different dose level.

2011-04-27 | GSE12716 | GEO

Administration of Probiotic Blend in Pancreatic Cancer Xenografted mice

Project description:Administration of Probiotic Blend in Pancreatic Cancer Xenografted mice

| PRJEB46072 | ENA

Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges

2012-01-01 | GSE34492 | GEO